COMMUNIQUÉS West-GlobeNewswire

Targovax ASA: First quarter 2018 results
03/05/2018
Oslo, Norway, 3 May 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its first quarter 2018 results. A meeting for [...]
IBA SA : IBA selected to install new proton therapy center in Italy
03/05/2018
IBA selected to install new proton therapy center in Italy Term sheet signed with the European Institute of Oncology (IEO) to install a Proteus ® ONE compact proton therapy solution in Milan Louvain-La-Neuve, Belgium, 3 [...]
IBA SA : IBA sélectionné pour l'installation d'un nouveau centre de protonthérapie en Italie
03/05/2018
IBA sélectionné pour l'installation d'un nouveau centre de protonthérapie en Italie Term sheet signée avec l'Institut Européen d'Oncologie (IEO) pour l'installation d'une solution compacte de protonthérapie Proteus ® [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
03/05/2018
REGULATED INFORMATION GHENT, Belgium, 3 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Medibio Receives CE Certification
03/05/2018
CE certification opens doors for further commercialization SYDNEY, Australia and MINNEAPOLIS, May 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology [...]
Summary Judgment Granted Upholding the Validity of Formulation Patent Protecting RELISTOR® Injection
03/05/2018
RELISTOR® Injection Protected from Generic Competition Until 2024 NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ) reported that its partner Valeant Pharmaceuticals [...]
Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections
02/05/2018
SOUTH SAN FRANCISCO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
Inspire Medical Systems, Inc. Announces Pricing of Initial Public Offering
02/05/2018
MINNEAPOLIS, May 02, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
FDA updates Trintellix® (vortioxetine) label to include data showing improvement in processing speed, an important aspect of cognitive function in acute Major Depressive Disorder (MDD)
02/05/2018
Trintellix ® (vortioxetine) is the first FDA-approved treatment for MDD to have data in the U.S. Prescribing Information showing a positive effect on processing speed, an aspect of cognitive function that is impaired in [...]
EDAP TMS SA : EDAP TMS SA to Announce First Quarter 2018 Financial Results on Monday, May 14
02/05/2018
LYON, France, May 2, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2018, after the close [...]
Avivagen Announces the Issuance of Shares
02/05/2018
OTTAWA, May 02, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]
Cara Therapeutics to Announce First Quarter 2018 Financial Results on May 9, 2018
02/05/2018
STAMFORD, Conn., May 02, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference
02/05/2018
BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Clearside Biomedical to Report First Quarter 2018 Financial Results on May 9, 2018 – Conference Call to Follow
02/05/2018
ALPHARETTA, Ga., May 02, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]
Dova Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 9, 2018
02/05/2018
DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) will host a conference call on Wednesday, May 9, 2018 at 4:30 p.m. ET to discuss first quarter 2018 financial results and recent [...]
Globus Medical Reports First Quarter 2018 Results
02/05/2018
AUDUBON, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018. Worldwide [...]
Dynavax to Host First Quarter 2018 Financial Results Conference Call
02/05/2018
BERKELEY, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that it will report financial results for the first quarter ended March 31, 2018 after market close on [...]
The Ensign Group Reports First Quarter Results
02/05/2018
Conference Call and Webcast scheduled for tomorrow, May 3, 2018 at 10:00 am PT MISSION VIEJO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of [...]
Humanigen Announces Preclinical Findings Presented on Lenzilumab’s Potential to Optimize CAR-T Therapy
02/05/2018
Lenzilumab effectively neutralizes GM-CSF CAR-T cells maintained robust anti-tumor activity in combination with lenzilumab GM-CSF depletion by lenzilumab may increase CAR-T expansion BRISBANE, Calif., May 02, 2018 ( [...]

Pages